Ark Therapeutics Signs Chinese Marketing Deal For Kerraboot Ulcer Product

Ark Therapeutics Group PLC said it has signed an exclusive licensing deal for its Kerraboot wound care device for the management of leg and foot ulcers with Chinese healthcare company Sino Tau International Company Lld in China.